A real-time RT-PCR assay intended for detecting nucleic acids from the SARS-CoV-2 virus and four of the most common strains of influenza (B Yamagata, B Victoria, A H1N1 and A H3N2).
This assays is expected to be ready for distribution soon. Please contact us for more information.
Intended use of CoviFlu™
PentaBase’s CoviFlu™ Multiplex RT-qPCR diagnostic assay is a real-time RT (reverse transcriptase) PCR assay intended for the detection of nucleic acids from the SARS-CoV-2 virus and the four most common strains of influenza (B Yamagata, B Victoria, A H1N1 and A H3N2). SARS-CoV-2 and influenza RNA can be found in the liquid from the upper or lower respiratory tracts of infected individuals. Samples can be obtained by nasopharyngeal or oropharyngeal swabs or from sputum.
Indications for use
The symptoms of SARS-CoV-2 have a lot in common with the symptoms of having influenza. A huge part of the symptomatic people tested will get a negative result for Covid-19 without knowing why they are symptomatic. PentaBase’s influenza COVID-19 multiplex RT-qPCR test is intended to identify the presence of SARS-CoV-2 virus or influenza RNA in humans by a fast and reliable method for a broader diagnose of symptomatic test persons compared to another COVID-19 test.
Available in following formats
Dispense Ready (DR)
Ready-To-Use (RTU)
The CoviFlu™ Multiplex RT-qPCR assay combines real-time PCR with PentaBase’s novel and selective technologies comprising both standard synthetic oligonucleotides as well as proprietary modified synthetic oligonucleotides such as HydrolEasy™, EasyBeacon™ probes, and SuPrimers™ for specific and sensitive amplification.
The technology is applicable on standard real-time PCR equipment using standard procedures. Pentabase-modified oligos contain synthetic DNA analogues comprising a flat heteroaromatic, hydrophobic molecule and a linker. These modifications are inserted into the oligonucleotides at fixed positions during synthesis. Using the CoviFlu™ test, the presence of virus RNA in a sample can be detected quickly, sensitively and selectively, by real-time RT-PCR analysis.
PentaBase systems for CoviFlu™ Assay
CoviFlu™ Multiplex RT-qPCR assay is now only designed to run on BaseTyper™ (PentaBase PCR instrument). Optimal PCR profiles are developed for each validated instrument. More instruments and settings will be added when they are validated.
